Clinical Trial Update: Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia [Phase 2]

View source ↗

Summary

Phase 2 trial update reports dose-escalating safety and preliminary efficacy of DaxibotulinumtoxinA for injection in cervical dystonia (torticollis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia
• Spasmodic Torticollis

Drugs mentioned

• DaxibotulinumtoxinA for Injection (daxibotulinumtoxinA)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Torticollis (Spasmodic) | Phase 2 | Status: COMPLETED